B.N. Ryzhov - Sistem psychology
Partners

WWW.SYSTEMPSYCHOLOGY.RU

 

Yu. L. Arzumanov, О. V. Korotina, А. А. Аbakumova, PERSONAL SPHERE PECULIARITIES IN PERSONS WITH SYNTHETIC PSYCHOACTIVE SUBSTANCE DEPENDENCE

Журнал » Journal_eng » Journal 30 : Yu. L. Arzumanov, О. V. Korotina, А. А. Аbakumova, PERSONAL SPHERE PECULIARITIES IN PERSONS WITH SYNTHETIC PSYCHOACTIVE SUBSTANCE DEPENDENCE
    Views: 43

PERSONAL SPHERE PECULIARITIES IN PERSONS WITH SYNTHETIC PSYCHOACTIVE SUBSTANCE DEPENDENCE

 

Yu. L. Arzumanov,

О. V. Korotina,

А. А. Аbakumova,

The Serbsky NMRC PN, Moscow,

arzumanov42@mail.ru,

ole4ka_koroti4@mail.ru,

abakumova46@mail.ru

 

Numerous clinical studies show that drug addicts, using synthetic psychoactive substances, quickly formed social maladjustment, higher risk of intoxication psychosis, often manifest emotional and personal disorders and violations of volitional processes, as well as more intensively manifested a number of negative consequences in the cognitive sphere, which are accompanied by systemic specific violations of attention, perception, memory, thinking.

This study aims to identify the emotional-personal characteristics of drug addicts who use synthetic psychoactive substance methylenedioxypyrovalerone (MDPV) in comparison with the group of healthy individuals on special scales short version of the Minnesota multi-factor personality questionnaire MMPI — method «Mini-mult».

It is revealed that the dependents are dominated by primitive everyday thinking, social maladjustment, indifferent attitude to their own lives, low productivity of mental activity, dysthymia. The data that show significant differences in the emotional and personal sphere on the profile scales of depression, psychasthenia and schizoid in drug addicts from psychoactive substance MDPV and healthy subjects. On a scale of «Depression» in dependent people performance is higher than in healthy individuals. This may be due to a high level of personal anxiety, growing sense of fear, panic, thoughts of death, low self-esteem, stigmatization of the disease of drug addiction and the formation of the personality of a drug addict. On the scales of «Psychasthenia» and «Schizoid» in people who use the drug, with a high degree of reliability, the indicators are lower than in healthy people. The decrease in the indicators on the scale of «Psychasthenia» in dependent people reveals such features as cowar dice, suspicion, distrust, caution, a tendency to lie, lack of will, a tendency to manipulation. Evaluation of the results on the scale of «Schizoid» indicates such traits as scarcity of thinking, a tendency to fantasize, resonance.

 

Keywords: psychoactive substances; synthetic cathinone; methylenedioxypyrovalerone (MDPV); drug dependent personality; personal sphere; willpower.

For citation: Arzumanov Yu. L., Korotina O. V., Abakumova A. A. Personal Sphere Peculiarities in Persons with Synthetic Psychoactive Substance Dependence // Systems Psychology and Sociology. 2019. № 2 (30). P. 13–23. DOI: 10.25688/2223-6872.2019.30.2.02

 

Arzumanov Yuriy Leonidovich, Doctor of Medical Sciences (MD), Professor, Head of the Laboratory of Clinical Neurophysiology at the National Scientific Research Institute for Addictions — a Branch of the Serbsky National Medical Research Center for Psychiatry and Narcology of the Ministry of Health of the Russian Federation, Moscow, Russia.

E-mail: arzumanov42@mail.ru

Korotina Olga Viktorovna, medical psychologist of the highest qualification category, Researcher at the Department of Psychotherapy and Medical Rehabilitation in Outpatient Setting at the National Scientific Research Institute for Addictions — a Branch of the Serbsky National Medical Research Center for Psychiatry and Narcology of the Ministry of Health of the Russian Federation, Moscow, Russia.

 E-mail: ole4ka_koroti4@mail.ru

Abakumova Alla Alekseyevna, PhD in Biology, Senior scientist at the Laboratory of Clinical Neurophysiology at the National Scientific Research Institute for Addictions — a Branch of the Serbsky National Medical Research Center for Psychiatry and Narcology of the Ministry of Health of the Russian Federation, Moscow, Russia.

E-mail: abakumova46@mail.ru

 

References

 

 

1. Antsyborov А. V., Mrykhin V. V. Synthetic cathinone «bath salts»: the mechanism of action, toxicological aspects, clinic, dependence development // Interactive science. 2017. № 5 (15). P. 29–39. DOI 10.21661/r-130075.

2. Arzumanov Yu. L., Lapin I. А., Metscheryakov A. F., Brodyansky V. М,, Abakumova А. А., Vinnikova М. А., Kibitov А. О. Electrophysiologycal correlates of genetic risk of alcohol addiction development // Journal of Addiction problems. 2016. № 2. P. 5–23.

3. Arzumanov Yu. L. Neurophysiological mechanisms of impaired cognitive activity in patients with hereditary substance dependence loading // Journal of Addiction problems. 2017. № 4–5. P. 5–22.

4. Аsadullin А. R. Clinical case intravenous use methylenedioxypyrovalerone (MDPV) patients with dependence syndrome synthetic stimulants // Neurological bulletin. Journal named after V. M. Bekhterev. 2016. Issue 2. P. 61–67.

5. Аsadullin А. R., Achmetova E. А., Аsadullina G. M., Sharipov А. R., Timerbulatova М. F. Suicides and synthetic cathinones. Clinical-genetic analysis // Tyumen Medical Journal. 2017. Т. 19. № 2. P. 12–14.

6. Berezin F. B., Miroshnikov M. P., Rozhanets R. V. Methodology of multilateral personality study (in clinical medicine and psychology). Moscow: Meditsina.1976. P. 5–186.

7. Glanz S. Biomedical statistics: translated from English. М.: Praktika. 1999. 459 p.

8. Golovko А. I., Barinov V. А., Bonitenko Е. Yu. and et al. Toxicological characterization of designer drugs // Medline.ru. Russian Biomedical Journal. 2015. Т. 16. № 4. P. 25–30.

9. Dmitrieva G. B., Drozdov A. Z., Kogan B. M. Peripheral indicators of serotonin metabolism in mental disorders // Russian journal of psychiatry. 2000. № 4. P. 52–56.

10. Draljuk N. М. Some characteristics of synthetic cathinone abuse // Narcology. 2018. Т. 17. № 1. P. 12–14.

11. Kogan B. M., Drozdov А. Z. Catecholamine neurotransmitter systems in mental disorders of addictive spectrum // Journal of Addiction Problems. 2017. № 2–3. P. 139–154.

12. Mendelevich V. D. Psychotic disorder due to drug abuse: current state of the problem // Narcology. 2010. № 7. P. 91–101.

13. Litvinova S. Yu., Yavorsky А. А. Квопросуопсихологическихдеформацияхунаркозависимых // Psychology, Sociology and Pedagogics. 2017. № 11. [Electronic resources]. URL: http://psychology. snauka.ru/2017/11/8415.

14. Rebrova О. Yu. Statistics for medical database. Packages of applied programs STATISTICA. Мoscow: Sfera. 2002. 305 p.

15. Sobchik L. N. Standardized multi-factor method for personality study. St. Petersburg: Retch, 2009. P. 55–61.

16. Tkachenko А. А., Drozdov А. Z., Peregozhin L. О., Kovaleva I. А., Kogan N. М. Content of serotonin in blood plasm and platelets, catch of serotonin by platelets in abnormal sexual identity in subjects with anomalous sexual behavior // Russian Journal of psychiatry. 1997. № 3. P. 37–41.

17. Chekhonin V. P., Baklaushev V. P., Kogan B. M., Savchenko E. A. and et al. Catecholamines and their metabolites in brain and urine of rats with experimental parkinsonism // Bulletin of Experimental Biology and Medicine. 2000. Vol. 130. № 8. P. 223–227.

18. Sharova E., Zlokazova M. Phenomenological peculiarities of psychic disorders caused by modern «designer» drugs // NarCom.ru: Practical medicine. 2017. № 1 (102). С. 23–25.

19. Shchukin А. М. To the issue of prevention of proliferation of smoking spice mixtures and salts in Tyumen region // Actual problems of fighting against crimes and other offences: the proceedings of the international conference. Barnaul: Izd-vo MVD Rossii. 2013. Part 1. P. 73–76.

20. Yushkova O. V. To the issue of differential diagnostics of salt intoxication // Tyumen journal of medicine. 2014. Vol. 16. № 3. P. 35–37.

21. Akhter A. Relationship between substance use and self esteem // International Journal of Scientific  & Engineering Research. 2013. Vol. 4. № 2. URL:https://www.ijser.org/ResearchPaperPublishing_February2013_Page5.aspx.

22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 5th ed. Arlington, VA: American Psychiatric Publishing, 2013. 970 p.

23. Bazhenova N., Khabibulin D., Tumbasova E. Сomparative analysis of values-based orientations in drug-dependent personalities and in non-addicted to drugs // Perspectives of Science and Education. 2018. № 36. P. 140–146. DOI: 10.32744/pse.2018.6.15.

24. Bhat S. A. The emerging problem of substance abuse // International Journal of Advanced Research and Development. 2017. Vol. 2. № 4. P. 492–495.

25. Brar R., Saluja A. Self-esteem of substance abusers and non abusers belonging to public schools of Delhi // International Journal of Humanities and Social Science Invention. 2015. Vol. 4. № 3. P. 26–30.

26. Coppola M., Mondola R. Synthetic cathinones: Сhemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as «bath salts or plant food» // Toxicology Letters. 2012. Vol. 211. № 2. P. 144–149.

27. Dunne E. M., Burrell L. I., Diggins A. D., Whitehead N. E., Latimer W. W. Increased risk for substance use and health‐related problems among homeless veterans // The American Journal on Addictions. 2015. № 24 (7). P. 676–680.

28. Munno D., Saroldi M., Bechon E., Sterpone S. Ch. M. Addictive behaviors and personality traits in adolescents // CNS Spectrums. 2016. V. 21. № 2. P. 207–213. DOI: https://doi.org/10.1017/ S1092852915000474.

29. Sivagnanam K., Chaudari D., Lopez P., Sutherland M. E., Ramu V. K. «Bath salts» induced severe reversible cardiomyopathy // American Journal of Medical Case Reports. 2013. № 14. P. 288–291.

30. Umebachi R., Aoki H., Sugita M., Taira T., Wakai S., Saito T., Inokuch S. Clinikal characteristics of a-pyrrolidinovalerophenone (a-PVP) poisoning // Journal of Clinical Toxicology. 2016. Vol. 54. № 7. P. 563–567.

31. Vanderplasschen W., Vandevelde S., Broekaert E. Therapeutic communities for treating addictions in Europe: evidence, current practices and future challenges // European Monitoring Centre for Drugs and Drug Addiction. 2014. URL: http://www.emcdda.europa.eu/attachements.cfm/att_226003_EN_TDXD14015ENN_final.pdf.